EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation

Justis P Ehlers, Allen Hu, David Boyer, Scott W Cousins, Nadia K Waheed, Philip J Rosenfeld, David Brown, Peter K Kaiser, Anthony Abbruscato, Gui Gao, Jeffrey Heier, ReCLAIM-2 (SPIAM-202) Study Investigators

Ophthalmology Science · 2025-01 · 5 (1) · 100628

DOI: 10.1016/j.xops.2024.100628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Science, 2025-01. Verfasst von Justis P Ehlers und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Age-related macular degenerationElamipretideEllipsoid zoneGeographic atrophyVisual acuity

Autor:innen und Institutionen

  • Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
  • Cumberland Valley Retina Consultants, Hagerstown, Maryland.
  • Retina-Vitreous Associates Medical Group, Beverly Hills, California.
  • Duke Eye Center, Durham, North Carolina.
  • New England Eye Center, Boston, Massachusetts.
  • Bascom Palmer Eye Institute, Miami, Florida.

Zitieren

APA

Ehlers, J. P., Hu, A., Boyer, D., Cousins, S. W., Waheed, N. K., Rosenfeld, P. J., Brown, D., Kaiser, P. K., Abbruscato, A., Gao, G., Heier, J., & ReCLAIM-2 (SPIAM-202) Study Investigators (2025). ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation. Ophthalmology Science, 5(1), 100628. https://doi.org/10.1016/j.xops.2024.100628

Vancouver

Ehlers JP, Hu A, Boyer D, Cousins SW, Waheed NK, Rosenfeld PJ, et al. ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation. Ophthalmology Science. 2025;5(1):100628. doi:10.1016/j.xops.2024.100628

BibTeX
@article{Ehlers2025,
  author = {Ehlers, Justis P and Hu, Allen and Boyer, David and Cousins, Scott W and Waheed, Nadia K and Rosenfeld, Philip J and Brown, David and Kaiser, Peter K and Abbruscato, Anthony and Gao, Gui and Heier, Jeffrey and ReCLAIM-2 (SPIAM-202) Study Investigators, ReCLAIM-2 (SPIAM-202) Study Investigators},
  title = {ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation},
  journal = {Ophthalmology Science},
  year = {2025},
  volume = {5},
  number = {1},
  pages = {100628},
  doi = {10.1016/j.xops.2024.100628}
}
Kostenlos starten →